Company intelligence / Profile preview
Macro Biologics
California, United Statesmacrobiologics.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Macro Biologics is preparing INDs for Amicidin-α Surgical and Amicidin-β Solution, with human clinical trials expected to follow. Products focus on prevention and treatment of infections via barrier, surfactant, and microbicidal activities.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Synthetic biological polymersMacro biologics
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
CARB-XU.S. Department of DefenseUK Global AMR Innovation Fund
Beyond the preview
Go deeper on Macro Biologics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Macro Biologics.